Mina J. Bissell
米娜·比塞尔
PhD
Distinguished Senior Scientist and Faculty Investigator, Biological Systems and Engineering Division生物系统与工程部杰出高级科学家兼研究员
👥Biography 个人简介
Mina Bissell is a Distinguished Senior Scientist at Lawrence Berkeley National Laboratory and one of the most original thinkers in cancer biology. For more than four decades, she has championed the concept that cancer is not simply a genetic disease determined by mutations in cancer cells, but is profoundly shaped by the tissue context — particularly the extracellular matrix (ECM) and the three-dimensional microenvironment in which cancer cells reside. Bissell's intellectual framework — which she terms "dynamic reciprocity" — holds that cells and their surrounding ECM engage in continuous bidirectional communication that governs gene expression, cell polarity, differentiation, and tissue architecture. In her seminal early work, she demonstrated that the Rous sarcoma virus gene product v-src causes cell transformation only when cells are cultured on plastic (2D) but fails to transform cells growing within physiological 3D collagen matrices — showing that tissue architecture can dominantly suppress oncogenic signals. This insight led to Bissell's development of three-dimensional (3D) culture systems for breast epithelial cells, particularly the laminin-rich reconstituted basement membrane (lrECM/Matrigel) system. In 3D culture, normal mammary epithelial cells self-organize into polarized, growth-arrested acinar structures that closely mimic the in vivo ductal morphology of the breast. Breast cancer cells, by contrast, fail to organize properly and continue proliferating. By manipulating specific ECM components, integrin signaling, and microenvironmental factors, Bissell's laboratory demonstrated that malignant breast cancer cells can be "reverted" to a non-malignant organized morphology — even without altering their underlying genomic mutations — proving that tissue context, not just genetics, determines the malignant phenotype. Bissell's work identified integrin β1 and downstream FAK/Rac1 signaling as critical mediators of tissue polarity and cancer suppression. She demonstrated how loss of normal ECM signaling destabilizes tissue architecture and permits oncogenic gene expression programs to manifest. She also showed that MMP (matrix metalloproteinase) remodeling of the ECM is a critical early step in mammary gland morphogenesis and breast cancer progression. Her contributions to understanding the role of tissue context in cancer have been recognized with numerous honors, and her TED talk "Experiments that point to a new understanding of cancer" has been widely viewed as a paradigm-shifting communication of her ideas to the broader public. She is a member of the National Academy of Sciences and American Academy of Arts and Sciences.
Mina Bissell 是劳伦斯伯克利国家实验室的杰出高级科学家,也是癌症生物学领域最具原创性的思想家之一。四十余年来,她一直倡导这样一个概念:癌症不仅仅是由癌细胞突变决定的遗传性疾病,还受到组织背景——特别是细胞外基质(ECM)和癌细胞所处的三维微环境——的深刻塑造。 她创造的"动态互惠性"框架证明,细胞与周围ECM之间的持续双向通讯支配着基因表达、细胞极性、分化和组织结构。她的三维乳腺培养系统证明,即使不改变底层基因组突变,恶性乳腺癌细胞也可以被"逆转"为非恶性的有序形态——证明组织背景与遗传学同样决定恶性表型。
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Dynamic Reciprocity — Tissue Microenvironment as Cancer Regulator
Established the "dynamic reciprocity" concept: that continuous bidirectional ECM-cell signaling governs gene expression and tissue architecture, and that disruption of this reciprocity is a prerequisite for malignant transformation. Demonstrated that the tissue microenvironment is not merely a passive scaffold but an active regulator that can suppress or promote oncogenic phenotypes independent of genomic mutations.
3D Culture Systems for Breast Epithelial Biology
Developed the laminin-rich reconstituted basement membrane 3D culture system, in which normal mammary epithelial cells self-organize into polarized acinar structures mimicking in vivo architecture, while cancer cells fail to do so. Used this system to demonstrate that restoring normal ECM signaling can "revert" malignant cells to organized, growth-arrested phenotypes without correcting their mutations.
Integrin β1 Signaling in Tissue Architecture and Cancer Suppression
Identified integrin β1 and downstream FAK/Rac1 signaling as critical mediators of normal mammary acinar architecture. Demonstrated that blocking integrin β1 function disrupts tissue polarity and permits malignant gene expression, while restoring normal integrin β1 signaling can suppress the malignant phenotype of breast cancer cells in 3D culture.
Representative Works 代表性著作
A Perspective on Cancer Cell Metastasis
Science (2011)
Paradigm-shifting perspective arguing that metastasis is governed by dynamic microenvironmental interactions rather than cell-intrinsic genetic programs alone, integrating ECM biology with the metastatic cascade.
Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies
Journal of Cell Biology (1997)
Demonstrated that blocking integrin β1 function reverts malignant human breast cancer cells to morphologically and functionally normal-like acinar structures in 3D culture, proving that tissue context can override oncogenic programming.
How does the extracellular matrix direct gene expression?
Journal of Theoretical Biology (1982)
Foundational theoretical paper introducing the dynamic reciprocity framework, proposing that ECM-nuclear communication is a fundamental regulatory axis in tissue biology and cancer.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-04-05 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 米娜·比塞尔 的研究动态
Follow Mina J. Bissell's research updates
留下邮箱,当我们发布与 Mina J. Bissell(Lawrence Berkeley National Laboratory)相关的新研究或访谈时,我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment